Cas no 258818-11-0 ((5-Aminopentyl)(ethyl)amine)

5-Aminopentyl(ethyl)amine is a bifunctional amine compound featuring both primary and secondary amine groups, making it a versatile intermediate in organic synthesis and pharmaceutical applications. Its linear aliphatic structure provides flexibility for conjugation and derivatization, while the amine functionalities enable participation in a wide range of reactions, including amide formation, reductive amination, and crosslinking. The compound is particularly useful in the development of chelating agents, surfactants, and polymer modifiers. Its balanced hydrophilicity and reactivity make it suitable for use in aqueous and organic media. Proper handling is required due to its alkaline nature and potential sensitivity to air and moisture.
(5-Aminopentyl)(ethyl)amine structure
(5-Aminopentyl)(ethyl)amine structure
Product Name:(5-Aminopentyl)(ethyl)amine
CAS No:258818-11-0
MF:C7H18N2
MW:130.231221675873
CID:2110018
PubChem ID:19032311
Update Time:2025-06-11

(5-Aminopentyl)(ethyl)amine Chemical and Physical Properties

Names and Identifiers

    • N1-ethylpentane-1,5-diamine
    • (5-aminopentyl)(ethyl)amine
    • N-Ethylcadaverine
    • NE59471
    • (5-Aminopentyl)(ethyl)amine
    • Inchi: 1S/C7H18N2/c1-2-9-7-5-3-4-6-8/h9H,2-8H2,1H3
    • InChI Key: PYMBPKPYZVMBOG-UHFFFAOYSA-N
    • SMILES: N(CC)CCCCCN

Computed Properties

  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 9
  • Rotatable Bond Count: 6
  • Complexity: 46.2
  • Topological Polar Surface Area: 38

(5-Aminopentyl)(ethyl)amine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
A630080-10mg
(5-aminopentyl)(ethyl)amine
258818-11-0
10mg
$ 70.00 2022-06-07
TRC
A630080-50mg
(5-aminopentyl)(ethyl)amine
258818-11-0
50mg
$ 250.00 2022-06-07
TRC
A630080-100mg
(5-aminopentyl)(ethyl)amine
258818-11-0
100mg
$ 365.00 2022-06-07
Enamine
EN300-173844-0.05g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
0.05g
$226.0 2023-09-20
Enamine
EN300-173844-0.1g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
0.1g
$337.0 2023-09-20
Enamine
EN300-173844-0.25g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
0.25g
$481.0 2023-09-20
Enamine
EN300-173844-0.5g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
0.5g
$758.0 2023-09-20
Enamine
EN300-173844-1.0g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
1g
$971.0 2023-05-24
Enamine
EN300-173844-2.5g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
2.5g
$1903.0 2023-09-20
Enamine
EN300-173844-5.0g
(5-aminopentyl)(ethyl)amine
258818-11-0 95%
5g
$2816.0 2023-05-24

Additional information on (5-Aminopentyl)(ethyl)amine

Professional Introduction to (5-Aminopentyl)(ethyl)amine (CAS No. 258818-11-0)

(5-Aminopentyl)(ethyl)amine, identified by the Chemical Abstracts Service Number (CAS No.) 258818-11-0, is a significant compound in the field of chemical and pharmaceutical research. This introduction provides a comprehensive overview of its chemical properties, applications, and recent advancements in its utilization within the pharmaceutical and biotechnology sectors.

The compound (5-Aminopentyl)(ethyl)amine is an organic amine with a molecular structure that includes both primary and secondary amine functional groups. Its molecular formula is C?H??N?, reflecting a chain of eight carbon atoms with ethyl and amine substituents. The presence of multiple amine groups makes it a versatile intermediate in organic synthesis, particularly in the development of pharmaceuticals and specialty chemicals.

In recent years, there has been growing interest in (5-Aminopentyl)(ethyl)amine due to its role as a building block in the synthesis of more complex molecules. Its structural features allow for modifications that can enhance binding affinity and selectivity, making it valuable in drug design. For instance, derivatives of this compound have been explored as potential ligands for enzyme inhibition and receptor modulation.

One of the most notable applications of (5-Aminopentyl)(ethyl)amine is in the development of peptide mimetics and peptidomimetics. These molecules mimic the structure and function of natural peptides but with improved stability and pharmacokinetic properties. The compound's ability to form stable hydrogen bonds and interact with biological targets makes it an ideal candidate for such applications. Recent studies have demonstrated its use in creating novel compounds that exhibit potent activity against various therapeutic targets.

The pharmaceutical industry has also leveraged (5-Aminopentyl)(ethyl)amine in the synthesis of small-molecule drugs. Its incorporation into drug candidates has led to the discovery of several promising compounds that are currently undergoing preclinical evaluation. These include molecules targeting neurological disorders, infectious diseases, and cancer. The versatility of this compound allows chemists to fine-tune its properties, optimizing it for specific biological interactions.

Advances in synthetic chemistry have further expanded the utility of (5-Aminopentyl)(ethyl)amine. Modern techniques such as flow chemistry and catalytic processes have enabled more efficient and scalable production methods. These innovations not only reduce costs but also improve the purity and yield of the final product. As a result, researchers can now access larger quantities of this compound for their studies, accelerating the pace of discovery.

In addition to its pharmaceutical applications, (5-Aminopentyl)(ethyl)amine has found utility in materials science and biotechnology. Its ability to form stable complexes with metal ions makes it valuable in the development of metal-organic frameworks (MOFs) and other functional materials. These materials have potential applications in gas storage, catalysis, and sensing technologies.

The biotechnology sector has also explored the use of (5-Aminopentyl)(ethyl)amine in protein engineering and molecular biology research. Its incorporation into peptides and proteins can alter their conformational properties, influencing their function and stability. This has opened up new avenues for developing biotherapeutics with enhanced efficacy and durability.

Recent research has highlighted the importance of understanding the stereochemistry of (5-Aminopentyl)(ethyl)amine. Studies have shown that enantiomeric purity can significantly impact the biological activity of derived compounds. Advances in chiral synthesis techniques have enabled researchers to produce enantiomerically pure forms of this compound, which are crucial for developing drugs with minimal side effects.

The environmental impact of synthesizing and using (5-Aminopentyl)(ethyl)amine is another area of growing interest. Researchers are actively exploring green chemistry approaches to minimize waste and reduce energy consumption during production. These efforts align with broader sustainability goals within the chemical industry, ensuring that compounds like this one can be produced responsibly.

In conclusion, (5-Aminopentyl)(ethyl)amine (CAS No. 258818-11-0) is a multifaceted compound with significant applications across multiple industries. Its role as an intermediate in pharmaceutical synthesis, its utility in materials science, and its contributions to biotechnology underscore its importance in modern research. As scientific understanding continues to evolve, it is likely that new applications for this compound will emerge, further solidifying its place as a cornerstone molecule in chemical innovation.

Recommended suppliers
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.